Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.


Allara raises $10M in Series A funding to address care gaps for women with chronic hormonal conditions.

Merging Menstrual Care with AI-enabled Health Monitoring: Tulipon launches on Indiegogo.

NYU Langone Health initiates digital intervention to address US maternal mortality rates with $12.5M NIH grant.

NHS Innovation Accelerator calls for US maternal and mental health innovations.

Unprude: Asia’s new sexual wellness app aims to challenge cultural taboos.

Daye and Lindus Health launch clinical trial to develop diagnostic tampon for at-home STI and HPV testing.

In the Know

The State of Menopause in 2023 (Femtech Insider)

When Brand Safety Undermines Social Progress: The Femtech Paradox (Femtech Insider)

Partner Features in Reproductive Health Apps: Empowerment or Overexposure? (Femtech Insider)

Climate action must focus on women’s health (The Guardian)

Even in femtech, it still pays to be a male founder (Sifted)

This biotech CEO decided to take her own (fertility) medicine (MIT Technology Review)

Endometriosis: black women continue to receive poorer care for the condition (The Conversation)

Show CommentsClose Comments

Leave a comment